These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


744 related items for PubMed ID: 8853261

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC, Lehman GA, Vasileva G, Malecka-Panas E, Gubergrits N, Shen Y, Sander-Struckmeier S, Caras S.
    Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of pancreatic insufficiency with a preparation containing high lipase activity].
    Pap A, Szilágyi V, Marosi E.
    Orv Hetil; 1997 Mar 09; 138(10):601-4. PubMed ID: 9157336
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative clinical study of Neopanpur and Creon].
    Beró T, Jávor T.
    Orv Hetil; 1994 Jan 02; 135(1):7-14. PubMed ID: 8290236
    [Abstract] [Full Text] [Related]

  • 10. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG, Lembcke B, Göke B, Creutzfeldt W.
    Z Gastroenterol; 1986 Dec 02; 24(12):753-7. PubMed ID: 3548109
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Replacement therapy in pancreatic insufficiency with a new pancreatin preparation respecting the physiological ratio of lipase/trypsin activity.
    Pap A, Varró V.
    Hepatogastroenterology; 1988 Apr 02; 35(2):83-6. PubMed ID: 3371850
    [Abstract] [Full Text] [Related]

  • 14. Alipase versus nonenteric-coated enzymes in pancreatic insufficiency. A french multicenter crossover comparative study.
    Gouerou H, Dain MP, Parrondo I, Poisson D, Bernades P.
    Int J Pancreatol; 1989 Apr 02; 5 Suppl():45-50. PubMed ID: 2702250
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
    Morrison G, Morrison JM, Redmond AO, Byers CA, McCracken KJ, Dodge JA, Guilford SA, Bowden MW.
    Aliment Pharmacol Ther; 1992 Oct 02; 6(5):549-55. PubMed ID: 1420747
    [Abstract] [Full Text] [Related]

  • 18. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
    Gan KH, Heijerman HG, Geus WP, Bakker W, Lamers CB.
    Aliment Pharmacol Ther; 1994 Dec 02; 8(6):603-7. PubMed ID: 7696449
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
    Konstan MW, Stern RC, Trout JR, Sherman JM, Eigen H, Wagener JS, Duggan C, Wohl ME, Colin P.
    Aliment Pharmacol Ther; 2004 Dec 02; 20(11-12):1365-71. PubMed ID: 15606399
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.